Announcement of Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. on changes in accounting policies
Securities code: 600436 Securities abbreviation: Pien Tze Huang Announcement number: 2026-014 Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd.
Announcement on changes in accounting policies
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
●This change in accounting policies will not have a significant impact on the financial status, operating results and cash flow of Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company"), and will not harm the interests of the company and shareholders.
●This change in accounting policies is made in accordance with the relevant provisions of the "Interpretation of Accounting Standards for Business Enterprises No. 19 (Financial Accounting [2025] No. 32)" (hereinafter referred to as "Interpretation of Standards No. 19") issued by the Ministry of Finance of the People's Republic of China (hereinafter referred to as the "Ministry of Finance"), and does not need to be submitted to the board of directors and shareholders' meeting for review.
1. Overview of this change in accounting policies
On December 5, 2025, the Ministry of Finance issued "Interpretation No. 19 of the Standards" No. "," which stipulates "About the accounting treatment of compensating assets in business combinations not under common control", "About the accounting treatment of relevant capital reserves when disposing of subsidiaries originally acquired through business combinations under common control", "About the derecognition of financial liabilities settled using electronic payment systems", "About the assessment and related disclosure of the contractual cash flow characteristics of financial assets", "About the disclosure of equity instruments designated as measured at fair value with changes included in other comprehensive income" and other related content. This policy will be implemented from January 1, 2026.
2. Changes in accounting policies
(1) Change date
1/2
According to "Interpretation No. 19 of the Standards", the company will implement the changed accounting policy from January 1, 2026.
(2) Accounting policies adopted by the company before the change
Before this accounting policy change, the company implemented the "Accounting Standards for Business Enterprises - Basic Standards" issued by the Ministry of Finance and various specific accounting standards, application guidelines for business accounting standards, interpretation announcements of business accounting standards and other relevant regulations.
(3) Accounting policies adopted by the company after the change
After this accounting policy change, the company's relevant accounting treatments will be implemented in accordance with the "Interpretation of Standards No. 19" issued by the Ministry of Finance. Other parts that have not been changed are still implemented in accordance with the "Accounting Standards for Business Enterprises - Basic Standards" and various specific accounting standards, the Application Guidelines for Accounting Standards for Business Enterprises, the Interpretation Announcement of Accounting Standards for Business Enterprises and other relevant regulations promulgated by the Ministry of Finance in the previous period.
3. The impact of this accounting policy change on the company
This change in accounting policy was made in accordance with the relevant regulations issued by the Ministry of Finance. The changed accounting policy can objectively and fairly reflect the company's financial status and operating results, and is in compliance with relevant laws and regulations and the company's actual situation.
This change in accounting policy has no impact on the company's current financial statements, and does not involve retrospective adjustments in previous years. This change in accounting policy will not have a significant impact on the company's financial status, operating results and cash flow, and will not harm the interests of the company and shareholders.
4. Others
This change in accounting policies is made in accordance with the relevant provisions of the "Standard Interpretation No. 19" issued by the Ministry of Finance and does not need to be submitted to the board of directors or shareholders' meeting for review.
Announcement is hereby made.
Board of Directors of Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd.
April 30, 2026
2/2